DEAR Stock Overview
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Duearity AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.40 |
| 52 Week High | kr9.00 |
| 52 Week Low | kr0.25 |
| Beta | 1.64 |
| 1 Month Change | -68.75% |
| 3 Month Change | -79.82% |
| 1 Year Change | -93.40% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -93.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| DEAR | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 10.8% | 1.9% | 0.6% |
| 1Y | -93.4% | -6.0% | 11.1% |
Return vs Industry: DEAR underperformed the Swedish Medical Equipment industry which returned -5.4% over the past year.
Return vs Market: DEAR underperformed the Swedish Market which returned 11.2% over the past year.
Price Volatility
| DEAR volatility | |
|---|---|
| DEAR Average Weekly Movement | 21.4% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 13.6% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: DEAR's share price has been volatile over the past 3 months.
Volatility Over Time: DEAR's weekly volatility has increased from 15% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 2 | Fredrik Westman | www.duearity.com |
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help people predict the symptoms and manage their problems. The company was incorporated in 2020 and is based in Malmö, Sweden.
Duearity AB (publ) Fundamentals Summary
| DEAR fundamental statistics | |
|---|---|
| Market cap | kr10.57m |
| Earnings (TTM) | -kr26.19m |
| Revenue (TTM) | kr1.65m |
6.4x
P/S Ratio-0.4x
P/E RatioIs DEAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEAR income statement (TTM) | |
|---|---|
| Revenue | kr1.65m |
| Cost of Revenue | kr5.83m |
| Gross Profit | -kr4.18m |
| Other Expenses | kr22.01m |
| Earnings | -kr26.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.99 |
| Gross Margin | -252.60% |
| Net Profit Margin | -1,583.43% |
| Debt/Equity Ratio | -443.7% |
How did DEAR perform over the long term?
See historical performance and comparison